WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kynurenic acid
- 1 November 1997
- journal article
- Published by Elsevier in Brain Research
- Vol. 774 (1-2) , 167-174
- https://doi.org/10.1016/s0006-8993(97)81700-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Hippocampal Serotonin 5‐HT1A Receptor Enhances Acetylcholine Release in Conscious RatsJournal of Neurochemistry, 1994
- Pharmacological and Immunohistochemical Evidence for Serotonergic Modulation of Cholinergic Nucleus Basalis NeuronsEuropean Journal of Neuroscience, 1993
- Cortical Pyramidal Neurone Loss May Cause Glutamatergic Hypoactivity and Cognitive Impairment in Alzheimer's Disease: Investigative and Therapeutic PerspectivesJournal of Neurochemistry, 1993
- A post-synaptic depressant modulatory action of 5-hydroxytryptamine on excitatory amino acid responses in rat entorhinal cortex in vitroNeuropharmacology, 1992
- Involvement of glycine site associated with the NMDA receptor in hippocampal long-term potentiation and acquisition of spatial memory in ratsBrain Research, 1992
- Reduced Glycine Stimulation of [3H]MK‐801 Binding in Alzheimer's DiseaseJournal of Neurochemistry, 1989
- Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotoninNature, 1987
- Place navigation impaired in rats with hippocampal lesionsNature, 1982
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982
- Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.BMJ, 1978